BridgeBio Pharma
BBIO · NASDAQ
Who owns BBIO
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 42.3% of BBIO’s shares.
- Janus Henderson Investors7.2%
- Farallon Capital Management, L.L.C.5.5%
- Viking Global Investors LP5.0%
- BlackRock Institutional Trust Company, N.A.4.6%
- Next 6 largest institutions20.0%
- All other shareholders57.7%
| Holder | Shares | % of shares |
|---|---|---|
| Janus Henderson Investors | 14.11M | 7.20% |
| Farallon Capital Management, L.L.C. | 10.74M | 5.49% |
| Viking Global Investors LP | 9.79M | 5.00% |
| BlackRock Institutional Trust Company, N.A. | 9.10M | 4.65% |
| Kohlberg Kravis Roberts & Co. L.P. | 8.26M | 4.22% |
| Vanguard Capital Management, LLC | 7.90M | 4.03% |
| Vanguard Portfolio Management, LLC | 7.66M | 3.91% |
| Kumar (Neil) | 5.32M | 2.71% |
| Wellington Management Company, LLP | 5.31M | 2.71% |
| Two Sigma Investments, LP | 4.74M | 2.42% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 5.62M | 2.87% |
| Vanguard Small-Cap Index Fund | 4.05M | 2.07% |
| Vanguard Health Care Fund | 2.64M | 1.35% |
| Vanguard Small-Cap Growth Index Fund | 2.34M | 1.20% |
| Statens Pensjonsfond Utland | 2.12M | 1.08% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $36.59M (55 trades) of BBIO on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Kumar Neil | Sale | 1.28K | $88.98K |
| Kumar Neil | Sale | 8.72K | $601.87K |
| Kumar Neil | Sale | 100 | $8.57K |
| Kumar Neil | Sale | 1.80K | $152.44K |
| Kumar Neil | Sale | 8.10K | $679.26K |
| Kumar Neil | Sale | 1.20K | $100.44K |
| Kumar Neil | Sale | 14.60K | $1.21M |
| Kumar Neil | Sale | 17.28K | $1.42M |
| Kumar Neil | Sale | 1.90K | $154.18K |
| Trimarchi Thomas | Tax withholding | 22.78K | $1.82M |
Congressional trades
Disclosed by members of Congress over the last 12 months
| Member | Type | Amount | Traded |
|---|---|---|---|
| Gilbert CisnerosHouse | Sale | $1K–$15K | Sep 29, 2026 |
| Gil CisnerosHouse | Purchase | $1K–$15K | Mar 19, 2026 |
| Gil CisnerosHouse | Purchase | $1K–$15K | Mar 18, 2026 |
| Gil CisnerosHouse | Purchase | $1K–$15K | Mar 3, 2026 |
Short interest
Settled Sep 30, 2026
- Shares short
- 19.67M
- Days to cover
- 5.85
- % of shares outstanding
- 10.04%
- Average daily volume
- 3.36M
- Change since last report
- −8.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.